8PD - Phase I JAVELIN solid tumor trial of avelumab (MSB0010718C), an anti-PD-L1 antibody: Safety and pharmacokinetics
| Autor: | Arkenau, H.-T., Kelly, K., Patel, M.R., Neuteboom, B., Speit, I., Chin, K., Heery, C.R., Gulley, J.L. |
|---|---|
| Zdroj: | In Annals of Oncology November 2015 26 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|